P. G. Dormer et al. / Tetrahedron Letters 45 (2004) 5429–5432
5431
The relative stereochemistries were assigned for the
major and minor ketals 8 and 9 using gradient NOE.11
Characterization and assignment of the relative stereo-
chemistry for ketal 10 was achieved from in situ moni-
toring (NMR) of the BF3 promoted cyclization (toluene-
d8) of the minor Michael adduct 7. Of interest, dihy-
droquinone 13 was also observed to slowly form
()20 °C, 5 h, <15%) in the NMR tube during this reac-
tion presumably due to hydrolysis of dimethylketal 7.
Upon gradual warming the reaction mixture from )20
to +67 °C, both ketal 10 and quinone 13 were converted
to the aromatized material 1a.
adducts from (+)-4a (>99% ee) and 5a (entry 8) were
cyclized with BF3 etherate and then aromatized with
TMSOTf, product (+)-1a was obtained with no loss of
enantiopurity. Similar results were obtained with enan-
tioenriched 2-mercaptoethanols ())-4a and (+)-4d (en-
tries 9 and 10), with no loss of enantiopurity upon
conversion to ())-1f and (+)-1d, respectively. Analogs of
the quinone ketal could also be utilized (entries 7 and 9).
The benzyl-substituted analog 5b, 2-benzyl-4,4-dimeth-
oxycyclohexa-2,5-dien-1-one, when reacted with 2-mer-
capto-1,2-diphenylethanol 4a (entry 7) afforded the
Michael adduct, which was cyclized and then aroma-
tized to produce 1f in 61% yield.
While only the syn isomer of 1a was observed in the
cyclization/aromatization sequence of the initial Michael
adduct (Table 1, entry 1), the presence of an electron
donating group (e.g., OMe) in the para-position of the
D-aromatic ring gave a mixture of syn and anti isomers
(Scheme 3). For example, with Ar1 ¼ 3-methoxyphenyl
and Ar2 ¼ 4-methoxyphenyl (4b, Table 1, entry 3)
cyclization of the initial Michael adducts (from 4b and
5a) and subsequent aromatization, using the TFA/tol-
uene/TMSOTf conditions, afforded a 1:1.6 syn:anti
mixture 1b. Formation of the anti isomer of 1b might
occur as proposed in Scheme 3. Ring opening of syn-1b
would afford the intermediate quinone 14. Bond rota-
tion, followed by 1,6-addition of the phenoxide to the
quinone would then produce anti isomer 1b. This
pathway can be suppressed by destabilizing quinone 14
through replacement of the para-methoxy group in the
D-ring with a less electron donating group. The use of
triflate on both the aryl rings of the mercaptoethanol
(4c, Table 1, entry 4) afforded only the syn isomer 1c
(50% assay, 29% isolated) upon treatment of the Mi-
chael adduct with TFA/toluene/)20 °C followed by
TMSOTf/)40 °C. Substitution of a halide for methoxy
in the para position of the D-ring (4d, Table 1, entry 5)
afforded only the syn-2,3-dihydro-1,4-benzo-ben-
zoxathiin 1d.
In conclusion, a novel, convenient, and effective syn-
thetic route to syn-2,3-disubstituted-2,3-dihydro-1,4-
benzoxathiins was developed. The starting materials are
readily available. The method lends itself to the prepa-
ration of a plethora of derivatives in good chemical yield
and high enantiopurity. Most importantly, chiral syn-
2,3-disubstituted-2,3-dihydro-1,4-benzoxathiins can be
readily prepared from enantioenriched mercaptoetha-
nols without any loss of optical activity.
Supplementary material
Representative experimental procedures for the prepa-
ration of 2-mercaptoethanols (4d) and for the Michael
addition, cyclization, and aromatization reactions
(4d+5a!1d). Also included is characterization data for
compounds 1a–f, 4a–e, 5a–b, 8–10.
Acknowledgements
We would like to thank Ms. Mirlinda Biba for the chiral
SFC and HPLC method development and enantiopurity
determinations. Also, we would like to thank Dr. Tho-
mas J. Novak for obtaining high resolution mass spec-
troscopic data.
As demonstrated above, the method works well for
disubstituted 2-mercaptoethanols (Table 1, entries 1–5).
It is possible to utilize mono-substituted 2-mercapto-
ethanols. For example, 4e (Table 1, entry 6) afforded 1e
in modest yield. Importantly, enantioenriched 2-mer-
captoethanols12;13 may also be used (Table 1, entries 8–
10) with no erosion of stereochemistry in the cyclization/
aromatization sequence. For example, when the Michael
References and notes
1. (a) Kim, S.; Wu, J. Y.; Chen, H. Y.; DiNino, F. Org. Lett.
2003, 5, 685–688; (b) Dinnino, F. P.; Hammond, M. L.
PCT Int. Appl. WO 2003087073; (c) Dinnino, F. P.;
Blizzard, T. A.; Morgan, J. D. II PCT Int. Appl. WO
2003091239.
2. (a) DiNino, F. P.; Wu, J. Y.; Kim, S.; Chen, H. Y. US
Patent 20020165226; (b) DiNino, F. P.; Chen, H. Y.; Kim,
S.; Wu, J. Y. PCT Int. Appl. WO 2002032377; (c) DiNino,
F. P.; Kim, S.; Wu, J. Y. PCT Int. Appl. WO 2002032373.
3. Satoh, J. Y.; Haruta, A. M.; Yokoyama, C. T.; Yamada,
Y.; Hirose, M. J. Chem. Soc., Chem. Commun. 1985, 1645–
1646.
4. Parham, W. E.; Jones, J. D. J. Am. Chem. Soc. 1954, 76,
1068–1074.
5. (a) Tegeler, J. J.; Ong, H. H.; Profitt, J. A. J. Heterocycl.
Chem. 1983, 20, 867–870; (b) Tanaka, H.; Shibata, M.;
Ohira, K.; Ito, K. Chem. Pharm. Bull. 1985, 33, 1419–
HO
S
HO
S
OMe
O
OMe
O
O
-
syn-1b
14
O
+
bond rotation
then ring
closure
C
D
HO
S
B
O
OMe
OMe
A
anti-1b
Scheme 3.